ANTI-AR AGENT AND RADIATION THERAPY FOR ANDROGEN RECEPTOR POSITIVE CANCER

摘要

Provided herein are compositions, systems, kits, and methods for treating cancer in a subject with androgen receptor positive cancer cells by sensitizing such cancer cells with anti-androgen receptor therapy (e.g., Enzalutamide or anti-androgen antibody), and then treating with radiation therapy.